Shane Ryan, in his first month as Country Lead for Takeda Products Ireland, speaks about his mandate to position Takeda as the leader in IBD and oncology with exciting new product launches, the evolving pharmaceutical and healthcare landscape in Ireland, and the drive to help patients that motivates him every day.
You were appointed Country Lead just over a month ago. What mandate were you given upon your appointment?
"Ireland’s healthcare landscape has evolved rapidly, particularly in light of the economic crisis of the late 2000s. Since then, there has been increasing pressure to ease the burden of state expenditure, including in the pharmaceutical and healthcare sectors."
